Clinical Success For Alzheimer’s Drug Worst In Last Decade
These results related to Alzheimer’s condition have been a story of the past and it is believed that various significant clinical researches are in their initial stages of development.
Washington, DC (I-Newswire) October 23, 2012 - Medical intervention in the field of Alzheimer’s therapeutic needs has been the most unsuccessful in the clinical world as only 3 medications have been approved till date from the last 13 years for treatment of this deadly brain disease.
The research in this field of clinical illness after the recent unsuccessful stories of two significant phase III clinical trial programs has caused a significant impact on the therapeutic profile of the drug manufacturing industries.
The pharmaceutical experts on the other hand claim that this failure rate has lend a message to the researchers to turn their scientific mistakes into big victories by learning from it and working on the accurate path.
The clinical professionals have claimed that the research allied to Alzheimer’s drug has revealed a terrible track record in R&D right from the year 1998 – 2011 as around 101 medications related to this condition have either been scrapped down or paused.
This 13 year hitch has resulted in a miserable win-to-loss ratio of an approximately 1 to 34 and thus, only 3 therapeutic medications out of the overall 101 have been approved by the pharmaceutical research and manufacturing companies all over the world.
As per some research group, there are around 93 medications in the pipeline pertaining to Alzheimer’s treatment and other mental stressful conditions such as dementia.
Also, around 5.4 million Americans have access to only 5 clinically approved medications for curing the symptoms associated with the disease and no therapeutic drugs that can reverse the progression of the disease.
For More please visit our site http://www.zeepharmacy.com
1600 Pennsylvania Ave,
1600 Pennsylvania Ave
Washington, DC, USA
Phone : 011-6654789986
Published in:Health & Fitness
Published On:October 23, 2012
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
NuCalm Available in Westchester at Asnis & Echelman Aesthetic Dentistry
The GHA - A New Project of MHR Corporation Is Launched
Lior Suchard, a World Renowned Super Mentalist Launches His Book ‘Mind Reader: Unlocking the Power of Your Mind to Get What You Want’
The Polycystic Liver: Webinar & Talk
Dr. Francis Murphy, DC Featured in USA Today